lilly
AstraZeneca teams up with rival Lilly for Alzheimer’s
September 16, 2014Research and Development, Sales and Marketing AZD3293, Alzheimer's, Alzheimer’s, AstraZeneca, BACE, lilly
AstraZeneca and US rival Lilly have signed an agreement to develop a new and experimental pill for the treatment of …
Lilly and Boehringer diabetes biosimilar sees EU approval
September 11, 2014Sales and Marketing Boehringer, EU, European Commission, Lantus, Sanofi, diabetes, lilly
Lilly and Boehringer Ingelheim’s insulin glargine product has been shown the green light by the European Commission (EC). The copycat …
Pharma firms give researchers access
July 22, 2014Research and Development, Sales and Marketing AstraZeneca, GlaxoSmithKline, Janssen R&D, MRC, Pfizer, Takeda, UCB, lilly, research, virtual library
UK researchers are to gain access to compounds from seven pharma companies in a partnership with the Medical Research Council …
Lilly signs Immunocore deal
July 17, 2014Research and Development, Sales and Marketing Cancer, Oxford, biotech, immunocore, lilly
Eli Lilly has signed a deal with one of the UK’s most high-profile biotech firms to research and potentially develop …
Lilly’s Efient tipped for expanded NICE approval
June 20, 2014Sales and Marketing Effient, Efient, FDA, NHS, blood, lilly, longston, thinner
Eli Lilly’s anti-platelet drug Efient has been given the nod by UK healthcare watchdog NICE for more widespread use, pending …
Lilly app targets depression
June 10, 2014Medical Communications, Sales and Marketing Android, depression, iphone, lilly, talking progress
Eli Lilly has launched a free mobile app for Android and iPhone handsets which aims to support patients who suffer …
Lilly the latest to open up data
June 4, 2014Medical Communications, Research and Development, Sales and Marketing Goldacre, NHS, alltrials, data, lilly, transparency, trials
Eli Lilly is to begin sharing its clinical trial data with scientific researchers through a website housing information from several …
Cialis OTC approval sought
June 2, 2014Sales and Marketing Cialis, ED, OTC, Sanofi, lilly
Sanofi and Eli Lilly have announced they are to push ahead with plans to seek regulatory approval for erectile dysfunction …
£47.5 million fund for UK life sciences
May 29, 2014Research and Development, Sales and Marketing European Investment Fund, Scottish Enterprise, Strathclyde Pension Fund, UK, epidarex, life sciences, lilly
A new fund has raised more than £47.5 million to help set up early-stage life science and health technology companies …
Merck’s vorapaxar gains long-awaited FDA approval
May 9, 2014Sales and Marketing Boehringer, FDA, Merck, lilly, vorapaxar, zontivity
Merck’s heart drug vorapaxar has finally been given the FDA go-ahead after looking dead in the water less than two …
Novartis reports healthy profit
April 25, 2014Sales and Marketing Afinitor, Gleevec, Glivec, Novartis, Q1, lilly
Multiple sclerosis drug Gilenya and cancer treatment Afinitor were among the biggest sellers for Novartis, as the Swiss company’s net …
GSK and Novartis sign multi-billion dollar deal
April 23, 2014Research and Development, Sales and Marketing GSK, Novartis, Tafinlar, lilly, merger, tykerb, vaccines
GlaxoSmithKline and Novartis are radically shaking up their businesses, starting up a joint venture while selling off major parts of …
Takeda and Lilly hit with $9 billion Actos damages bill
April 8, 2014Medical Communications, Sales and Marketing Actos, Takeda, law case, lilly
A US jury has ordered Japanese firm Takeda Pharmaceutical to pay $6 billion (£3.6 billion) in punitive damages, over claims …
Lundbeck teams up with Lieber Institute
April 3, 2014Research and Development, Sales and Marketing Astellas, AstraZeneca, Lundbeck, Pfizer, Roche, ability, brain, lieber, lilly
Lundbeck has entered into a new partnership with the Lieber Institute for Brain Development in the hope of discovering new …
Europe grants Eperzan licence
March 27, 2014Sales and Marketing Bydureon, GSK, diabetes, eperzan, lilly
The European Commission has granted marketing authorisation to GlaxoSmithKline’s new diabetes treatment Eperzan – setting the manufacturer on a collision …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
